Puma Biotech (PBYI) Reports Q2 Loss of $1.13
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Join SI Premium – FREE
Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.13), versus ($1.05) reported last year.
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- Volato Group reports Q2 2026 preliminary results with Vaunt growth
- KeyBanc: 'We Like AT&T (T) and TMUS'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
